RYONCIL Trademark

Trademark Overview

On Tuesday, February 26, 2019, a trademark application was filed for RYONCIL with the United States Patent and Trademark Office. The USPTO has given the RYONCIL trademark a serial number of 88978590. The federal status of this trademark filing is REGISTERED as of Tuesday, September 22, 2020. This trademark is owned by Mesoblast International Sàrl. The RYONCIL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical, biotechnology and medication preparations and substances for the prevention, management, diagnosis, and treatment of inflammatory and/or degenerative disorders and conditions for medical and surgical purposes
ryoncil

General Information

Serial Number88978590
Word MarkRYONCIL
Filing DateTuesday, February 26, 2019
Status700 - REGISTERED
Status DateTuesday, September 22, 2020
Registration Number6160286
Registration DateTuesday, September 22, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 2, 2019

Trademark Statements

Goods and ServicesPharmaceutical, biotechnology and medication preparations and substances for the prevention, management, diagnosis, and treatment of inflammatory and/or degenerative disorders and conditions for medical and surgical purposes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 18, 2019
Primary Code005
First Use Anywhere DateSunday, May 31, 2020
First Use In Commerce DateSunday, May 31, 2020

Trademark Owner History

Party NameMesoblast International Sàrl
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressMeyrin 1217
CH
Party NameMesoblast International Sàrl
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressMeyrin 1217
CH
Party NameMesoblast International Sàrl
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressMeyrin 1217
CH

Trademark Events

Event DateEvent Description
Friday, March 1, 2019NEW APPLICATION ENTERED
Monday, March 18, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 7, 2019ASSIGNED TO EXAMINER
Tuesday, May 14, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 14, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 14, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, May 14, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, May 15, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 29, 2019ASSIGNED TO LIE
Wednesday, May 29, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 12, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 2, 2019PUBLISHED FOR OPPOSITION
Tuesday, July 2, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 27, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 13, 2020SOU TEAS EXTENSION RECEIVED
Thursday, February 13, 2020SOU EXTENSION 1 FILED
Thursday, February 13, 2020SOU EXTENSION 1 GRANTED
Saturday, February 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 1, 2020TEAS STATEMENT OF USE RECEIVED
Wednesday, July 1, 2020TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, July 1, 2020DIVISIONAL REQUEST RECEIVED
Wednesday, July 1, 2020USE AMENDMENT FILED
Monday, August 3, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 20, 2020DIVISIONAL PROCESSING COMPLETE
Friday, August 21, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 22, 2020REGISTERED-PRINCIPAL REGISTER
Monday, September 22, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, August 20, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 20, 2020STATEMENT OF USE PROCESSING COMPLETE

Related Keywords

ryoncil disorders degenerative inflammatory conditions medical purposes surgical treatment diagnosis medication